Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD
9.11
-0.39 (-4.11%)
Mar 28, 2025, 4:00 PM EDT - Market closed
-4.11%
Market Cap 124.87M
Revenue (ttm) 58.59M
Net Income (ttm) 6.43M
Shares Out 13.71M
EPS (ttm) 0.46
PE Ratio 19.92
Forward PE 151.83
Dividend n/a
Ex-Dividend Date n/a
Volume 59,783
Open 9.72
Previous Close 9.50
Day's Range 9.05 - 9.70
52-Week Range 3.60 - 11.99
Beta 0.20
Analysts Strong Buy
Price Target 12.00 (+31.72%)
Earnings Date Mar 11, 2025

About CSBR

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Mar 25, 1986
Employees 210
Stock Exchange NASDAQ
Ticker Symbol CSBR
Full Company Profile

Financial Performance

In 2024, Champions Oncology's revenue was $50.16 million, a decrease of -6.90% compared to the previous year's $53.87 million. Losses were -$7.28 million, 36.4% more than in 2023.

Financial Statements

Analyst Forecast

According to one analyst, the rating for CSBR stock is "Strong Buy" and the 12-month stock price forecast is $12.0.

Price Target
$12.0
(31.72% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Maj Soueidan...

19 days ago - Seeking Alpha

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, toda...

19 days ago - Accesswire

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will ...

24 days ago - Accesswire

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the accep...

5 weeks ago - Accesswire

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to annou...

2 months ago - Accesswire

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Champoins Oncology broke out of a multiyear downtrend following its Q2'25 earnings. Management has embarked on a one-way journey to reduce working capital and grow the business with zero incremental c...

3 months ago - Seeking Alpha

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Conference Call December 11, 2024 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Office...

3 months ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

HACKENSACK, NJ / ACCESSWIRE / December 11, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ...

3 months ago - Accesswire

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will re...

4 months ago - Accesswire

Champions Oncology Announces Agreement with Weill Cornell Medicine

HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agre...

5 months ago - Accesswire

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Conference Call September 11, 2024 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Offic...

7 months ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, toda...

7 months ago - Accesswire

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report i...

7 months ago - Accesswire

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2024 Earnings Conference Call July 18, 2024 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matthew Hewit...

9 months ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Annual Revenue of $50.2 Million HACKENSACK, NJ / ACCESSWIRE / July 18, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, today anno...

9 months ago - Accesswire

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will repor...

9 months ago - Accesswire

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with ...

10 months ago - Accesswire

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

1 year ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $12.0 Million

HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ann...

1 year ago - Accesswire

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced ...

1 year ago - Accesswire

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

HACKENSACK, NJ / ACCESSWIRE / March 6, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its f...

1 year ago - Accesswire

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Conference Call December 12, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Operator Greetings. Welcome to the Cha...

1 year ago - Seeking Alpha

Champions Oncology Reports Quarterly Revenue of $11.6 Million

HACKENSACK, NJ / ACCESSWIRE / December 12, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ...

1 year ago - Accesswire

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

HACKENSACK, NJ / ACCESSWIRE / December 4, 2023 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report it...

1 year ago - Accesswire

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announc...

1 year ago - Accesswire